Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

CCSD code 0051G: Urine guanidinoacetate (GUAN) billing guide

Key Takeaways

Key Takeaways

CCSD code 0051G is a diagnostic pathology code that bills the laboratory measurement of urine guanidinoacetate (GUAN), used to investigate suspected disorders of creatine synthesis.

Major UK insurers including Bupa, AXA Health, Allianz Care, and Aviva base their fee schedules on CCSD codes – each sets its own reimbursement rate independently.

Incomplete or mismatched documentation is the leading cause of claim denials for CCSD-coded lab tests. Confirm code acceptance with the relevant insurer portal before submitting.

Practice management software like Pabau, including its claims management tools, helps UK private practices track lab test submissions and reduce administrative errors at the point of invoice.

CCSD code 0051G bills the laboratory measurement of urine guanidinoacetate (GUAN), a test ordered when a patient is being investigated for a suspected disorder of creatine synthesis or transport.

The code sits within the diagnostic schedule maintained by the Clinical Coding and Schedule Development (CCSD) Group, covered in more depth on Pabau’s diagnostic codes hub, which UK private insurers use alongside the separate procedure codes schedule for clinical interventions.

This guide covers what CCSD code 0051G is, how it fits within the CCSD’s diagnostic schedule, which insurers accept CCSD-coded lab claims, what documentation a claim needs, and how to submit it correctly. It also covers the errors that most commonly trigger rejections for pathology codes in this range.

CCSD code 0051G: Definition and clinical classification

CCSD code 0051G is published by the Clinical Coding and Schedule Development (CCSD) Group, the body that maintains the standard coding system for procedures and diagnostic tests across UK private healthcare.

The CCSD schedule is split into a procedural schedule for clinical interventions, such as CCSD code 0264F, and a diagnostic schedule for pathology and laboratory tests.

Code 0051G belongs to the diagnostic schedule: It identifies a laboratory test, not a surgical or clinical procedure performed on the patient. Other diagnostic-schedule entries, such as CCSD code 0430B, follow the same pathology-first structure.

The narrative for 0051G covers urine guanidinoacetate (GUAN), a marker used in the biochemical investigation of creatine deficiency syndromes. Guanidinoacetate is the precursor molecule that the enzyme guanidinoacetate methyltransferase (GAMT) converts into creatine.

Elevated urine GAA points toward GAMT deficiency, while unusually low levels are associated with arginine:glycine amidinotransferase (AGAT) deficiency. Both are rare inherited disorders that can cause developmental delay, intellectual disability, and movement problems if left undiagnosed.

Because the full CCSD schedule requires a registered login to access, providers should confirm the current narrative against their CCSD account or the CCSD Technical Guide (October 2025 edition) before billing.

The trailing letter in CCSD pathology codes is often described as a specimen marker, but the CCSD Group does not publish one universal letter-to-specimen key across the whole schedule: CCSD code 0035G uses the same “G” suffix for a procedural entry, so the letter alone should never be assumed to mean urine, blood, or any other sample.

What is confirmed for 0051G specifically, from its published narrative, is the specimen: This test is run on a urine sample.

How CCSD codes are structured

CCSD codes follow a consistent format: A four-digit numeric prefix followed by an alphabetic suffix.

In the diagnostic schedule, the numeric portion groups related pathology tests, and the full code maps to a single entry in the NHS National Laboratory Medicine Catalogue. This differs from how the US HCPCS system is structured for equipment and supply billing, such as HCPCS code K0738, where the prefix denotes an equipment category rather than a specimen.

Coders should verify a pathology code’s specimen and narrative against the current CCSD schedule rather than inferring it from the suffix alone.

Code elementWhat it indicatesExample
Numeric prefix (0051)Test group reference within the CCSD diagnostic (pathology) schedule0051 = a specific pathology test cluster
Alpha suffix (G)Part of the unique identifier for this test entry; not a reliable stand-alone specimen indicator across the whole schedule0051G = urine guanidinoacetate (GUAN)
Schedule typeDiagnostic/pathology schedule, not procedural0051G is a laboratory test code, not a surgical or clinical procedure
Narrative descriptionOfficial test nameUrine guanidinoacetate (GUAN); confirm via registered CCSD login

The CCSD schedule is updated periodically. Before billing any code, check the current narrative via the CCSD website or your registered schedule access to confirm the description has not changed in the most recent release.

Which insurers accept CCSD codes

CCSD codes are the standard coding system for UK private healthcare, covering both procedures and pathology tests. Most major health insurers operating in the UK base their fee schedules on the CCSD schedule, though each sets its own contracted fee rates independently.

Using a recognized CCSD code does not guarantee a specific reimbursement amount: That depends on your contracted rate with each insurer.

The principal insurers accepting CCSD-based billing in the UK are listed below. For Bupa CCSD codes, the dedicated code search portal at codes.bupa.co.uk lets recognized providers look up accepted codes and associated fees. AXA Health uses a separate specialist procedure codes portal. Allianz Care recognizes providers billing CCSD-based pathology tests through its own provider network.

  • Bupa: Uses CCSD codes for all procedure and pathology billing. Recognized providers submit via Healthcode or Bupa’s online portal. Fee schedules vary by contract.
  • AXA Health: CCSD-based codes form the basis of specialist billing. Contracted fees are listed on the AXA Health specialist procedure codes portal.
  • Allianz Care: Recognizes CCSD-based test and procedure codes across its UK provider network. Check current fee guidance through Allianz Care’s healthcare provider resources portal.
  • Aviva: CCSD-based billing; submit via Healthcode or direct portal submission depending on your recognition agreement.
  • H3 Insurance: Fee schedule explicitly based on the CCSD Schedule.
  • Vitality, WPA, Cigna UK, Healix: All operate CCSD-based fee schedules. Check each insurer’s provider portal for code-specific acceptance.

Reimbursement is determined by each insurer individually. The CCSD Group sets the coding standard but has no role in setting fees. Before billing CCSD code 0051G, confirm its acceptance with the relevant insurer.

If the code is not listed in an insurer’s schedule, the claim will be rejected regardless of how accurately it is submitted. Practices transitioning to private practice often encounter this distinction for the first time when dealing with multiple insurer schedules simultaneously.

Pro Tip

Verify CCSD code 0051G with each insurer’s portal before submitting your first claim. Bupa’s code search tool and AXA Health’s specialist portal both let recognized providers check code acceptance and associated fees. A five-minute check before ordering a new test type prevents weeks of denial management later.

Documentation requirements for CCSD code 0051G

Insufficient documentation is the single most common reason CCSD-coded claims are rejected or queried by UK private insurers. Every insurer expects the submitted invoice to align precisely with the clinical record and the laboratory report. For a pathology code, that means the request, the specimen, and the reported result all need to support the code that was billed.

For CCSD code 0051G, the request should document the clinical reason for testing, such as suspected creatine deficiency syndrome, unexplained developmental delay, or follow-up on an abnormal genetic finding.

The request should also carry a supporting ICD-10 diagnosis code. A broader nutritional or metabolic presentation might be coded under ICD-10 code E58 pending a specific metabolic diagnosis, so check with the ordering clinician if the diagnosis field looks incomplete.

Using digital forms for clinical documentation reduces transcription errors and keeps the request record aligned with the submitted code at the point of care rather than during retrospective review.

Digital forms
Digital forms

Core documentation checklist

  • Test request record: The clinical notes or referral must document the reason for testing in terms consistent with the CCSD code narrative. A vague note (“bloods and urine sent”) is insufficient.
  • Specimen and collection details: Confirm the specimen type (urine) and collection date match both the laboratory report and the invoice.
  • Referring or reporting practitioner credentials: The invoicing practitioner or laboratory must be recognized by the insurer for this test. Unrecognized providers will result in automatic rejection.
  • Date of service: The specimen collection or reporting date must match the date on the invoice exactly. Discrepancies are a common trigger for audits.
  • Patient details: Full name, date of birth, and insurer membership number as they appear on the policy. Even minor spelling discrepancies can delay processing.
  • Supporting clinical information: Some insurers may request the full laboratory report, prior creatine or creatinine results, or a specialist referral letter depending on the clinical picture. Check insurer-specific requirements before first submission.

Practices coordinating follow-up care after an abnormal result can use a structured action plan template to track next steps with the referring clinician and the family.

UK private healthcare billing is subject to UK GDPR and the Data Protection Act 2018. Clinical records used to support insurance claims must be stored securely, accessible only to authorized personnel, and retained in line with your practice’s data retention policy. The Information Commissioner’s Office (ICO) regulates data handling, and non-compliance carries financial penalties separate from any insurer dispute.

Practices should also maintain data protection best practices for all billing-related records. Insurer audits can request documentation going back several years, and incomplete historical records create liability even when the original claim was paid without dispute.

Streamline your UK private healthcare billing

Pabau supports UK private practices with claims management, digital documentation, and automated workflows that reduce billing errors and rework across procedure and pathology test claims.

Pabau practice management platform for UK private healthcare

How to submit CCSD code 0051G correctly

Electronic submission is the standard for UK private healthcare billing. Most major insurers require or strongly prefer claims submitted through Healthcode, the UK’s private healthcare electronic billing network.

For pathology tests, the laboratory or the referring practice may submit the claim depending on the recognition agreement in place. Paper invoices are accepted by some insurers but carry a higher risk of processing delays and data-entry errors.

Submission steps

  1. Confirm code acceptance: Before billing, verify CCSD code 0051G is accepted by the relevant insurer for the patient’s policy type. Use the insurer’s provider portal or code search tool.
  2. Match the narrative: Ensure the request and laboratory report use language consistent with the CCSD code narrative. Access the current narrative via your registered CCSD schedule login.
  3. Prepare the invoice: Include the correct CCSD code, specimen collection or service date, referring or reporting practitioner details, and patient membership number. Do not group multiple CCSD codes unless the insurer’s fee schedule explicitly permits it under their bundling rules.
  4. Submit via Healthcode or insurer portal: Most Bupa, AXA Health, Aviva, and Allianz Care claims are submitted through Healthcode. Some insurers have their own submission portals. Check recognition agreements for the preferred channel.
  5. Retain acknowledgment records: Keep a record of submission confirmation numbers and timestamps. If a claim is queried or rejected, these records are essential for appeals.
  6. Track payment against submission: Reconcile payments against submitted CCSD codes to identify patterns of rejection. Repeated rejections for the same code indicate either a documentation problem or a contracted fee dispute requiring escalation.

Practices managing multiple CCSD codes and multiple insurer relationships benefit significantly from dedicated claims management software that tracks submission status, flags pending items, and supports reconciliation without manual spreadsheet work. This matters most when billing several insurers simultaneously, each with different code acceptance rules and processing timelines.

When insurers pay, Pabau does the heavy lifting for you
When insurers pay, Pabau does the heavy lifting for you

For practices with private practice billing essentials still being established, setting up an organized submission workflow from the start prevents unresolved claims from piling up as test volumes grow.

Pro Tip

Do not assume a CCSD code accepted by one insurer is automatically accepted by all. Acceptance and fee rates vary by insurer and by contract year. Review your recognition agreements annually, particularly following CCSD schedule updates, which can change code narratives, introduce new codes, or retire existing ones.

Common billing errors that trigger rejections

Claim rejections for CCSD codes follow predictable patterns. Most are avoidable with a pre-submission check process. The errors below account for the majority of denied or queried claims in UK private healthcare billing.

Errors by category

Error typeWhat goes wrongHow to prevent it
Wrong code or specimen mismatchBilling 0051G when the sample tested was plasma rather than urine, or vice versaCross-check the exact CCSD code narrative and specimen type before entry
Unrecognized practitionerSubmitting under a referring or reporting practitioner not recognized by the insurer for this testVerify practitioner recognition before requesting the test
Bundling violationsBilling CCSD code 0051G alongside related metabolic panel tests the insurer considers includedCheck insurer-specific bundling rules; Healix publishes detailed unbundling guidelines
Documentation mismatchClinical notes or referral describe a different test than the code billedComplete the request at the time of testing, not retrospectively
Expired or retired codeBilling a code that has been amended or retired in the current CCSD scheduleCheck CCSD schedule updates at the start of each contract year
Membership number errorIncorrect patient membership number causes claim to reject at eligibility checkVerify membership number directly from the patient’s insurance card at registration

Bundling and unbundling rules deserve particular attention. Some insurers, including Healix, publish explicit fee schedule guidelines specifying which codes may not be billed together. Where a CCSD pathology code includes related markers within its narrative, billing those separately will be treated as unbundling and rejected.

The Care Quality Commission oversight framework adds a further layer of documentation expectations for registered providers, since CQC inspections can review billing and laboratory records as part of governance assessments.

Practices that implement structured features that save private practices time on administrative review typically catch the majority of these errors before submission, rather than managing them as post-rejection corrections. A pre-submission checklist reviewed by a trained billing coordinator is the simplest operational control.

Conclusion

CCSD code 0051G follows the same billing logic as every CCSD code: The documentation must support the narrative, the practitioner must be recognized, and the submission must go through the correct channel for each insurer.

Because it is a laboratory test rather than a procedure, the supporting evidence centers on the request and the lab report rather than an operative note. Most rejections come from documentation and process failures, not from errors at the point of code selection.

Pabau’s claims management software helps UK private practices track submissions, manage rejections, and maintain the documentation trail that supports clean first-time claims. To see how Pabau supports private healthcare billing workflows, book a demo with the team.

Continue your research

Continue your research

Need a complete overview of CCSD codes for Bupa? Bupa CCSD codes guide covers the full Bupa procedure schedule, code lookup, and submission requirements for recognized UK providers.

Unsure how to handle UK data protection in your billing records? UK GDPR compliance checklist outlines the key obligations for private practices storing and processing patient billing data.

Looking for Bupa fee schedule details? Bupa procedure codes and fee schedule provides a structured reference for Bupa-recognized codes and reimbursement guidance.

Frequently Asked Questions

What is CCSD code 0051G?

CCSD code 0051G is a diagnostic pathology code within the Clinical Coding and Schedule Development (CCSD) Group schedule. It covers the laboratory measurement of urine guanidinoacetate (GUAN), a test used to investigate suspected disorders of creatine synthesis such as GAMT deficiency. Confirm the exact narrative via your CCSD account or the October 2025 Technical Guide before submitting a claim.

What is urine guanidinoacetate testing used for?

Urine guanidinoacetate testing measures a precursor molecule in the creatine synthesis pathway. Elevated levels can indicate guanidinoacetate methyltransferase (GAMT) deficiency, while unusually low levels are associated with arginine:glycine amidinotransferase (AGAT) deficiency. Clinicians typically request it when investigating unexplained developmental delay, intellectual disability, or movement problems in a patient with suspected creatine deficiency syndrome.

Which insurers use CCSD codes for billing?

Most major UK private health insurers use CCSD codes, including Bupa, AXA Health, Aviva, Allianz Care, Vitality, WPA, Cigna UK, Healix, and H3 Insurance. Each insurer sets its own fee schedule and contracted rates independently of the CCSD Group, so acceptance and reimbursement amounts vary by insurer and by practitioner recognition agreement.

What documentation is required to submit a CCSD code 0051G claim?

At minimum, you need a test request that documents the clinical reason for testing, the laboratory report confirming the specimen type and result, the patient’s insurer membership number, and the recognition credentials of the referring or reporting practitioner. Some insurers require additional supporting documents, such as prior creatine or creatinine results, depending on the clinical picture and policy type.

How do I submit CCSD codes to Bupa or AXA Health?

Bupa and AXA Health both accept electronic submissions through Healthcode, the UK’s private healthcare billing network. Bupa also provides a code search portal at codes.bupa.co.uk where recognized providers can verify code acceptance. AXA Health’s specialist procedure codes portal lists contracted fees for recognized specialists. Always confirm the preferred submission channel in your recognition agreement with each insurer before submitting for the first time.

×